Back
Sangamo Therapeutics, Inc. 10K Form
Sell
32
SGMO
Sangamo Therapeutics, Inc.
Last Price:
$0.53
Seasonality Move:
5.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SGMO News And Ratings
See the #1 stock for the next 7 days that we like better than SGMO
SGMO Financial Statistics
Sales & Book Value
| Annual Sales: | $57.8M |
|---|---|
| Cash Flow: | $-28.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.02 |
| Price / Book: | 26.91 |
Profitability
| EPS (TTM): | -0.44280 |
|---|---|
| Net Income (TTM): | $-108.9M |
| Gross Margin: | $48.4M |
| Return on Equity: | -587.71% |
| Return on Assets: | -111.37% |
Sangamo Therapeutics, Inc. Earnings Forecast
Key Sangamo Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 22 years for SGMO is 83.80%.
-
The Selling, General & Administrative Expenses for SGMO have been equal to 77.38% of Gross Profit Margin.
-
The Research & Development expenses have been 192.52% of Revenue.
-
The Net Earning history of SGMO is -169.45% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 8 years.
Sangamo Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SGMO |
| CUSIP: | 800677 |
| Website: | sangamo.com |
Debt
| Debt-to-Equity Ratio: | 4.07 |
|---|---|
| Current Ratio: | 0.88 |
| Quick Ratio: | 0.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SGMO Technical Analysis vs Fundamental Analysis
Sell
32
Sangamo Therapeutics, Inc. (SGMO)
is a Sell
Is Sangamo Therapeutics, Inc. a Buy or a Sell?
-
Sangamo Therapeutics, Inc. stock is rated a SellThe current Sangamo Therapeutics, Inc. [SGMO] share price is $0.50. The Score for SGMO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.